Organizing Committee Member
Didier Betbeder
Professor
University of Lille
France
Biography
Pr. Didier BETBEDER has 25 years’ experience in drug delivery using colloids, ranging from basic research to clinical studies. Working with the World Health Organisation he obtained his PhD in 1988 on drug targeting to treat sleeping sickness, before spending 2 years as a post-doctoral fellow at the University of Warwick (England). He was then engaged by BioEurope, a company specialising in biocatalysis, before joining Biovector Therapeutics (France) as Research director from 1992 – 2001. He is Professor at the University of Artois and Lille 2 since 2001.
Research Area
He developed from research to clinical development a technology based on polysaccharide nanoparticles. He conducted 5 clinical trials. Nasal flu vaccine formulations have been clinically trailed with BioChem Pharma (Canada),and SmithKline Beecham (Belgium). His researches are focusing on studying the mechanisms implied in nanoparticles interactions within mucosa. He has extensive experience in Nanomedicine, over 110 international publications and 23 patents to his name. He is the founder of VAXINANO a company who is developing vaccines for human and animal health (www.vaxinano.com)